Tianjin Union Medical Center
10
2
3
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
20%
2 trials in Phase 3/4
100%
1 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer
Role: collaborator
Diagnosis, Treatment, and Prevention of Colorectal Cancer Amid Abnormal Lipid Metabolism
Role: lead
Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis
Role: collaborator
Herbal Treatment to Improve Chemotherapy Delivery
Role: collaborator
Effect of Low-dose Esketamine Combined With Target-controlled Infusion of Propofol for Painless Gastrointestinal Endoscopy
Role: lead
Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III
Role: collaborator
Nutrition and Lifestyle Study Cohort of Colorectal Cancer in China
Role: collaborator
Nutrition and Lifestyle Study Cohort of Gastric Cancer in China
Role: collaborator
Intracranial Artery Stenosis Magnetic Resonance Imaging: Aetiology and Progression
Role: collaborator
Evaluate the Nephrotoxicity by 6% Hydroxyethyl Starch 130/0.4 in Old Patients During Orthopaedic Surgery
Role: collaborator
All 10 trials loaded